RECRUITINGINTERVENTIONAL
T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
T1CARE: A Randomized Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
About This Trial
Randomized controlled trial with a wait list control arm. Participants will be randomized 1:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator at Project Access-New Haven.
Who May Be Eligible (Plain English)
Who May Qualify:
- Type 1 Diabetes
- fluent in Spanish or English who reside in the greater New Haven area
Who Should NOT Join This Trial:
- cognitive impairment and otherwise unable to give written willing to sign a consent form about participating in this study
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Type 1 Diabetes
* fluent in Spanish or English who reside in the greater New Haven area
Exclusion Criteria:
* cognitive impairment and otherwise unable to give written informed consent about participating in this study
Treatments Being Tested
BEHAVIORAL
T1CARE
The intervention includes navigation by a Community Health Navigator (CHN), who will assess and help address patients' SDOH-related needs, coordinate care, and provide social support.
Locations (2)
Yale Adult Diabetes Center
New Haven, Connecticut, United States
Yale Children's Diabetes Center
New Haven, Connecticut, United States